|
Receptors
Citations 1-10 of 25 total displayed.
|
Most recent content
(1 Aug 2010):
|
- Commentaries
Costimulatory Blockade to Prevent Osteoclastogenesis, Inflammation, or Both?
- Julia F. Charles and Mary C. Nakamura
IBMS BoneKEy 2010; 7: 287-290.
[Full text]
[PDF]
|
Past content
(since Mar 2001):
|
- Perspectives
PPAR , an Essential Regulator of Bone Mass: Metabolic and Molecular Cues
- Beata Lecka-Czernik
IBMS BoneKEy 2010; 7: 171-181.
[Abstract]
[Full text]
[PDF]
- Commentaries
RANKing Bone Resorption Versus Inflammation: Infection Makes the Decision
- Sylvie Ferrari-Lacraz and Danielle Burger
IBMS BoneKEy 2010; 7: 156-160.
[Full text]
[PDF]
- Perspectives
N-Cadherin-Wnt Connections and the Control of Bone Formation
- Pierre J. Marie
IBMS BoneKEy 2009; 6: 150-156.
[Abstract]
[Full text]
[PDF]
- Perspectives
Non-Canonical Wnt Signaling: What Is Its Role in Bone?
- Joseph Caverzasio
IBMS BoneKEy 2009; 6: 107-115.
[Abstract]
[Full text]
[PDF]
- Perspectives
Effects of RANKL Inhibition on Inflammation and Immunity
- Sylvie Ferrari-Lacraz and Serge Ferrari
IBMS BoneKEy 2009; 6: 116-126.
[Abstract]
[Full text]
[PDF]
- Perspectives
Mimetic Ligands for the PTHR1: Approaches, Developments, and Considerations
- Thomas J. Gardella
IBMS BoneKEy 2009; 6: 71-85.
[Abstract]
[Full text]
[PDF]
- Commentaries
Wnt Signaling, LRP5 and Gut Serotonin: Have We Been Targeting the Right Pathway for the Wrong Reasons?
- Roland Baron
IBMS BoneKEy 2009; 6: 86-93.
[Full text]
[PDF]
- NEWS
Denosumab and the Treatment of Rheumatoid Arthritis: In an Occupied Field, Where Will a RANKL Inhibitor Fit In?
- Neil A. Andrews
IBMS BoneKEy 2008; 5: 351-356.
[Full text]
[PDF]
- Commentaries
A New PPAR- Function in Bone
- Ichiro Takada and Shigeaki Kato
IBMS BoneKEy 2008; 5: 258-261.
[Full text]
[PDF]
|
|
